Rankings
▼
Calendar
ZBIO Q1 2025 Earnings — Zenas BioPharma, Inc. Revenue & Financial Results | Market Cap Arena
ZBIO
Zenas BioPharma, Inc.
$1B
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$10M
Gross Profit
$10M
100.0% margin
Operating Income
-$37M
-373.3% margin
Net Income
-$34M
-335.7% margin
EPS (Diluted)
$-0.80
QoQ Revenue Growth
+100.0%
Cash Flow
Operating Cash Flow
-$37M
Free Cash Flow
-$37M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$334M
Total Liabilities
$49M
Stockholders' Equity
$284M
Cash & Equivalents
$197M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$10M
$0
—
Gross Profit
$10M
-$23M
+144.2%
Operating Income
-$37M
-$28M
-35.4%
Net Income
-$34M
-$28M
-20.8%
← Q4 2024
All Quarters
Q2 2025 →